According to Hikma Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.50. At the end of 2023 the company had a P/S ratio of 1.76.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.76 | 8.28% |
2022 | 1.62 | -49.82% |
2021 | 3.24 | -13.54% |
2020 | 3.74 | 11.6% |
2019 | 3.36 | 19.05% |
2018 | 2.82 | 32.14% |
2017 | 2.13 | -35.88% |
2016 | 3.33 | -48.17% |
2015 | 6.42 | 21.76% |
2014 | 5.27 | 53.56% |
2013 | 3.43 | 28.54% |
2012 | 2.67 | 10.12% |
2011 | 2.42 | -35.58% |
2010 | 3.76 | 31.97% |
2009 | 2.85 | 73.09% |
2008 | 1.65 | -64.97% |
2007 | 4.70 | -13.94% |
2006 | 5.47 |